Wexford Capital’s OptiNose OPTN Stock Holding History

Wexford Capital’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-649	Closed	-$40K	–	300
2020 Q4	$40K	Buy	+649	New	+$39.8K	0.01%	243

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wexford Capital's OPTN Position: Q1 2021 in Review

Wexford Capital sold out of OptiNose (OPTN) in Q1 2021, closing a stake of 649 shares — an estimated $40K sold.

Wexford Capital first reported a position in OPTN in Q4 2020 and held it in 1 quarter. The position peaked at $40K in Q4 2020. 68 funds tracked by Wall St. Rank hold OPTN as of Q1 2021.

Wexford Capital reported no remaining OptiNose position as of Q1 2021 after selling out during the quarter.
Wexford Capital sold 649 OptiNose shares in Q1 2021, an estimated $40K.
Wexford Capital first reported a position in OptiNose in Q4 2020 and held it in 1 quarter.
Wexford Capital's OptiNose position peaked at $40K in Q4 2020.
68 funds tracked by Wall St. Rank held OptiNose as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.